Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$784M |
| 2 |
Amgen
AMGN
|
$695M |
| 3 |
Eli Lilly
LLY
|
$512M |
| 4 |
Apple
AAPL
|
$485M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$471M |
Top Sells
| 1 |
Adobe
ADBE
|
$935M |
| 2 |
NVIDIA
NVDA
|
$837M |
| 3 |
TJX Companies
TJX
|
$533M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$364M |
| 5 |
Starbucks
SBUX
|
$357M |
Sector Composition
| 1 | Technology | 35.94% |
| 2 | Healthcare | 18.89% |
| 3 | Consumer Discretionary | 9.38% |
| 4 | Financials | 9.11% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Akero Therapeutics
AKRO
$3.58B
| $161M | 0.09% |
6,876,253
+754,283
| +12% | +$17.7M |
|
202
Illumina
ILMN
$15.7B
| $161M | 0.09% |
1,542,812
-2,244,941
| -59% | -$234M |
|
203
Magnolia Oil & Gas
MGY
$4.38B
| $160M | 0.09% |
6,295,440
-102,003
| -2% | -$2.58M |
|
204
Palo Alto Networks
PANW
$130B
| $159M | 0.09% |
936,112
-1,382
| -0.1% | -$234K |
|
205
Apollo Global Management
APO
$75.3B
| $158M | 0.08% |
1,334,463
-438,023
| -25% | -$51.7M |
|
206
American Electric Power
AEP
$57.8B
| $157M | 0.08% |
1,791,125
-37,409
| -2% | -$3.28M |
|
207
Las Vegas Sands
LVS
$36.9B
| $156M | 0.08% |
3,517,511
-1,812,512
| -34% | -$80.2M |
|
208
nVent Electric
NVT
$14.9B
| $151M | 0.08% |
1,975,112
-35,400
| -2% | -$2.71M |
|
209
Johnson & Johnson
JNJ
$430B
| $151M | 0.08% |
1,033,002
+45,846
| +5% | +$6.7M |
|
210
Avidity Biosciences
RNA
$6.48B
| $149M | 0.08% |
3,656,843
+2,414,010
| +194% | +$98.7M |
|
211
Applovin
APP
$166B
| $149M | 0.08% |
1,790,242
+1,779,595
| +16,715% | +$148M |
|
212
McKesson
MCK
$85.5B
| $148M | 0.08% |
253,321
+234,014
| +1,212% | +$137M |
|
213
Williams Companies
WMB
$69.9B
| $148M | 0.08% |
3,477,726
-10,597
| -0.3% | -$450K |
|
214
Occidental Petroleum
OXY
$45.2B
| $145M | 0.08% |
2,304,794
-533,973
| -19% | -$33.7M |
|
215
Intercontinental Exchange
ICE
$99.8B
| $145M | 0.08% |
1,060,543
+256,036
| +32% | +$35M |
|
216
Vanguard Total International Stock ETF
VXUS
$102B
| $144M | 0.08% |
2,382,143
-99,502
| -4% | -$6M |
|
217
IDEAYA Biosciences
IDYA
$2.38B
| $143M | 0.08% |
4,076,020
+267,570
| +7% | +$9.39M |
|
218
Verizon
VZ
$187B
| $142M | 0.08% |
3,445,220
-7,855
| -0.2% | -$324K |
|
219
Euronet Worldwide
EEFT
$3.74B
| $141M | 0.08% |
1,364,908
-25,987
| -2% | -$2.69M |
|
220
Insmed
INSM
$30.7B
| $140M | 0.08% |
2,091,778
-137,685
| -6% | -$9.22M |
|
221
CCC Intelligent Solutions
CCCS
$6.4B
| $139M | 0.07% |
12,520,730
+51,306
| +0.4% | +$570K |
|
222
Alight
ALIT
$2B
| $138M | 0.07% |
18,700,914
-359,567
| -2% | -$2.65M |
|
223
Soleno Therapeutics
SLNO
$3.71B
| $137M | 0.07% |
3,358,873
+488,062
| +17% | +$19.9M |
|
224
Marriott International Class A Common Stock
MAR
$71.9B
| $137M | 0.07% |
565,501
+835
| +0.1% | +$202K |
|
225
Encompass Health
EHC
$12.6B
| $136M | 0.07% |
1,580,384
+27,613
| +2% | +$2.37M |
|